"SPRI Clinical Trials is a highly experienced, independent, free-standing clinical research site located in Brooklyn, NY that collaborates with the pharmaceutical industry in their evaluation of medications that may eventually be used to treat a number of important health-related conditions. Some of the medications being evaluated are newly developed compounds, while others have already been approved and available as treatments for other illnesses."

During the past decade, SPRI Clinical Trials, LLC conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 25 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 21 clinical trials were completed. i.e. 161.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SPRI Clinical Trials, LLC" #1 sponsor was "Pfizer" with 6 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "ACADIA Pharmaceuticals Inc." with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SPRI Clinical Trials, LLC" #1 collaborator was "Cognitive Research Corporation" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "SPRI Clinical Trials, LLC" are "Alzheimer's Disease" (8 trials), "Depressive Disorder, Major" (7 trials), "Migraine" (5 trials), "Depression" (3 trials) and "Migraine, With or Without Aura" (3 trials). Many other conditions were trialed in "SPRI Clinical Trials, LLC" in a lesser frequency.

Most popular intervention types in "SPRI Clinical Trials, LLC" are "Drug" (44 trials), "Biological" (3 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Rapastinel" (4 trials), "Rimegepant" (4 trials), "BMS-820836" (2 trials) and "Dihydroergotamine" (2 trials). Other intervention names were less common.

The vast majority of trials in "SPRI Clinical Trials, LLC" are 44 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "SPRI Clinical Trials, LLC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in SPRI Clinical Trials, LLC, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in SPRI Clinical Trials, LLC, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".